Published in Curr Pharm Des on January 01, 2016
Omega-3 and Omega-6 Fatty Acids Act as Inhibitors of the Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Activity. Protein J (2017) 0.75
Simvastatin modulates gingival cytokine and MMP production in a rat model of ligature-induced periodontitis. Clin Cosmet Investig Dent (2017) 0.75
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (1998) 32.73
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (1993) 25.54
Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 25.43
Inflammation and insulin resistance. J Clin Invest (2006) 18.76
Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med (2008) 18.27
A central role for JNK in obesity and insulin resistance. Nature (2002) 17.27
The pathobiology of diabetic complications: a unifying mechanism. Diabetes (2005) 14.96
Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med (1989) 13.83
Macrophage plasticity and polarization: in vivo veritas. J Clin Invest (2012) 13.44
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest (2006) 12.32
IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med (2005) 12.07
Macrophages, inflammation, and insulin resistance. Annu Rev Physiol (2010) 11.77
Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol (2009) 11.63
Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med (2007) 11.62
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell (2010) 10.96
CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest (2005) 10.44
Periodontal diseases. Lancet (2005) 10.13
Resolution of inflammation: the beginning programs the end. Nat Immunol (2005) 9.81
A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol (2002) 8.79
Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med (2004) 8.36
Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med (2002) 7.99
Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest (1989) 7.60
PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab (2007) 7.19
Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA (2008) 6.15
P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev (2002) 6.14
Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A (2003) 6.06
Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol (2007) 5.83
Periodontal disease and cardiovascular disease. J Periodontol (1996) 5.78
Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol (2010) 5.59
The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother (2002) 5.58
Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 5.46
The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev (2007) 5.19
Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol (2009) 5.03
Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med (2005) 5.00
Treatment of periodontitis and endothelial function. N Engl J Med (2007) 4.83
Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem (2003) 4.58
Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med (1997) 4.57
Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest (1992) 4.40
Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 4.38
Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol (2005) 4.30
Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet (2006) 4.13
Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature (2004) 3.65
Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature (2005) 3.62
Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A (2010) 3.51
Type 1 diabetes. Lancet (2013) 3.45
Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med (2008) 3.35
Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care (2000) 3.35
Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation (2005) 3.25
Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. Diabetes Care (2010) 3.17
Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int (2007) 3.09
Treatment of periodontal disease for glycaemic control in people with diabetes. Cochrane Database Syst Rev (2010) 3.08
Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol (2000) 3.07
The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus. J Clin Periodontol (2005) 3.04
The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol (2009) 2.91
The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol (2003) 2.83
Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J (2009) 2.83
Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol (2007) 2.83
The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev (2006) 2.80
Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol (2006) 2.80
Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu Rev Pharmacol Toxicol (2009) 2.78
Periodontal diseases: pathogenesis. Ann Periodontol (1996) 2.71
Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol (2007) 2.66
Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000 (1997) 2.62
Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother (2006) 2.47
Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci U S A (1984) 2.46
IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol (1998) 2.45
Relationship between periodontal disease, tooth loss, and carotid artery plaque: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Stroke (2003) 2.45
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis (2010) 2.40
Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity (2013) 2.39
Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol (2006) 2.37
The composition of food consumed by Greenland Eskimos. Acta Med Scand (1976) 2.27
Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J Dent Res (2010) 2.26
The global burden of periodontal disease: towards integration with chronic disease prevention and control. Periodontol 2000 (2012) 2.12
Cytokines that promote periodontal tissue destruction. J Periodontol (2008) 2.11
Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J (1996) 2.09
The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology (2000) 2.08
Risk factors for periodontal disease. Periodontol 2000 (2013) 2.07
Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action. Diabetes Care (2007) 2.04
Targeting inflammation in the treatment of type 2 diabetes: time to start. Nat Rev Drug Discov (2014) 2.03
Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev (2010) 1.97
Does periodontal care improve glycemic control? The Department of Veterans Affairs Dental Diabetes Study. J Clin Periodontol (2006) 1.97
Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest (2010) 1.93
Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol (2003) 1.92
Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care (2007) 1.92
Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol (1996) 1.90
Deadly encounter: ubiquitin meets apoptosis. Nat Rev Mol Cell Biol (2002) 1.89
Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J Immunol (2011) 1.87
15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation. J Exp Med (2004) 1.84
Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. J Clin Invest (1998) 1.83
Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest (2000) 1.82
The diversity of the lipoxygenase family. Many sequence data but little information on biological significance. FEBS Lett (1999) 1.78
Macrophage polarization and plasticity in health and disease. Immunol Res (2012) 1.78
COX-2 inhibitors and cardiovascular risk. J Cardiovasc Pharmacol (2007) 1.77
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol (2008) 11.02
Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray. J Periodontol (2009) 3.66
The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol (2009) 2.91
Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol (2007) 2.66
Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol (2006) 2.37
Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol (2003) 2.23
The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol (2008) 2.21
The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol (2009) 2.20
Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol (2007) 1.98
Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis. J Periodontol (2003) 1.74
Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arterioscler Thromb Vasc Biol (2003) 1.69
Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: a multicenter trial. J Periodontol (2004) 1.59
Compliance as a prognostic indicator: retrospective study of 505 patients treated and maintained for 15 years. J Periodontol (2006) 1.58
The Periodontitis and Vascular Events (PAVE) pilot study: adverse events. J Periodontol (2008) 1.55
Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J Biol Chem (2009) 1.50
Impact of periodontal therapy on the subgingival microbiota of severe periodontitis: comparison between good responders and individuals with refractory periodontitis using the human oral microbe identification microarray. J Periodontol (2012) 1.47
Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol (2009) 1.38
Hereditary gingival fibromatosis associated with generalized aggressive periodontitis: a case report. J Periodontol (2004) 1.36
Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontol (2013) 1.30
Impaired phagocytosis in localized aggressive periodontitis: rescue by Resolvin E1. PLoS One (2011) 1.29
Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol (2013) 1.22
Prevention: Reducing the risk of CVD in patients with periodontitis. Nat Rev Cardiol (2010) 1.21
Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000 (2014) 1.20
Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase. J Leukoc Biol (2008) 1.19
Oral infection, hyperglycemia, and endothelial dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 1.18
TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients. J Immunol (2009) 1.16
Role for periodontitis in the progression of lipid deposition in an animal model. Infect Immun (2003) 1.16
Origin and function of the cellular components in gingival crevice fluid. Periodontol 2000 (2003) 1.16
Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol 2000 (2013) 1.16
A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage. J Immunol (2004) 1.12
Diabetes-induced oxidative stress is mediated by Ca2+-independent phospholipase A2 in neutrophils. J Immunol (2010) 1.11
Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin. J Periodontol (2010) 1.10
Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes. J Leukoc Biol (2006) 1.10
Modeling of trabecular bone and lamina dura following selective alveolar decortication in rats. J Periodontol (2008) 1.09
Resolvin E1 regulates adenosine diphosphate activation of human platelets. Arterioscler Thromb Vasc Biol (2010) 1.09
Oral inflammatory diseases and systemic inflammation: role of the macrophage. Front Immunol (2012) 1.07
Clinical characteristics and microbiota of progressing slight chronic periodontitis in adults. J Clin Periodontol (2007) 1.05
The etiology and pathogenesis of periodontitis revisited. J Appl Oral Sci (2009) 1.03
Lipoxins in chronic inflammation. Crit Rev Oral Biol Med (2003) 1.02
Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice. J Immunol (2006) 1.02
Mice lacking inducible nitric oxide synthase demonstrate impaired killing of Porphyromonas gingivalis. Infect Immun (2003) 1.01
Phosphorylation of pleckstrin increases proinflammatory cytokine secretion by mononuclear phagocytes in diabetes mellitus. J Immunol (2007) 0.98
Mechanism of action and morphologic changes in the alveolar bone in response to selective alveolar decortication-facilitated tooth movement. Am J Orthod Dentofacial Orthop (2011) 0.98
Natural resolution of inflammation. Periodontol 2000 (2013) 0.97
Systemic MMP inhibition for periodontal wound repair: results of a multi-centre randomized-controlled clinical trial. J Clin Periodontol (2009) 0.97
B cells from periodontal disease patients express surface Toll-like receptor 4. J Leukoc Biol (2008) 0.96
Aggressive periodontitis: 5-year follow-up of treatment. J Periodontol (2002) 0.95
Paradigm shift in the pharmacological management of periodontal diseases. Front Oral Biol (2011) 0.94
The Periodontitis and Vascular Events (PAVE) pilot study: recruitment, retention, and community care controls. J Periodontol (2008) 0.94
PMN responses in chronic periodontal disease: evaluation by gingival crevicular fluid enzymes and elastase-alpha-1-proteinase inhibitor complex. J Clin Periodontol (2002) 0.93
Host-mediated resolution of inflammation in periodontal diseases. Periodontol 2000 (2006) 0.93
Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. J Immunol (2012) 0.92
Porphyromonas gingivalis lipid A phosphatase activity is critical for colonization and increasing the commensal load in the rabbit ligature model. Infect Immun (2013) 0.92
Cardiovascular disease and periodontal diseases: commonality and causation. Compend Contin Educ Dent (2004) 0.91
Salivary lysozyme and prevalent coronary heart disease: possible effects of oral health on endothelial dysfunction. Arterioscler Thromb Vasc Biol (2006) 0.91
A stable aspirin-triggered lipoxin A4 analog blocks phosphorylation of leukocyte-specific protein 1 in human neutrophils. J Immunol (2004) 0.90
Lipoxin signaling in neutrophils and their role in periodontal disease. Prostaglandins Leukot Essent Fatty Acids (2005) 0.90
CD38 cleavage in fMLP- and IL-8-induced chemotaxis is dependent on p38 MAP kinase but independent of p44/42 MAP kinase. Cell Signal (2005) 0.89
Localized aggressive periodontitis is linked to human chromosome 1q25. Hum Genet (2003) 0.89
Neutrophil-mediated host response to Porphyromonas gingivalis. J Int Acad Periodontol (2002) 0.88
Performance of multiplex cytokine assays in serum and saliva among community-dwelling postmenopausal women. PLoS One (2013) 0.88
Gingipain-specific IgG in the sera of patients with periodontal disease is necessary for opsonophagocytosis of Porphyromonas gingivalis. J Periodontol (2005) 0.87
Resolvin D1 protects periodontal ligament. Am J Physiol Cell Physiol (2013) 0.86
In vivo up-regulation of kinin B1 receptors after treatment with Porphyromonas gingivalis lipopolysaccharide in rat paw. J Pharmacol Exp Ther (2009) 0.86
Association between interleukin-1 genotype and periodontal disease in a diabetic population. J Periodontol (2003) 0.86
iNOS-derived nitric oxide stimulates osteoclast activity and alveolar bone loss in ligature-induced periodontitis in rats. J Periodontol (2011) 0.85
Association of salivary lysozyme and C-reactive protein with metabolic syndrome. J Clin Periodontol (2010) 0.85
Resolution of crevicular fluid leukocyte activity in patients treated for aggressive periodontal disease. J Periodontol (2002) 0.84
The multi-center randomized controlled trial (RCT) published by the journal of the American Medical Association (JAMA) on the effect of periodontal therapy on glycated hemoglobin (HbA1c) has fundamental problems. J Evid Based Dent Pract (2014) 0.83
Treatment of intrabony defects using guided tissue regeneration and autogenous spongiosa alone or combined with hydroxyapatite/beta-tricalcium phosphate bone substitute or bovine-derived xenograft. J Periodontol (2007) 0.83
Differential effects of growth factors and cytokines on the synthesis of SPARC, DNA, fibronectin and alkaline phosphatase activity in human periodontal ligament cells. Cell Biol Int (2004) 0.83
Bringing light to the heat: "inflammation and periodontal diseases: a reappraisal". J Periodontol (2008) 0.83
Resolution of inflammation in periodontitis. J Periodontol (2005) 0.83
Resolvin E1 regulates osteoclast fusion via DC-STAMP and NFATc1. FASEB J (2013) 0.83
Sequential chemotactic and phagocytic activation of human polymorphonuclear neutrophils. Infect Immun (2007) 0.82
Differentiation of HL-60 cells to granulocytes involves regulation of select diacylglycerol kinases (DGKs). J Cell Biochem (2005) 0.82
A critical role for suppressors of cytokine signaling 3 in regulating LPS-induced transcriptional activation of matrix metalloproteinase-13 in osteoblasts. PeerJ (2013) 0.82
Ceruloplasmin induces polymorphonuclear leukocyte priming in localized aggressive periodontitis. J Periodontol (2009) 0.81
Local and cardiorenal effects of periodontitis in nitric oxide-deficient hypertensive rats. Arch Oral Biol (2010) 0.81
Role for moesin in lipopolysaccharide-stimulated signal transduction. Infect Immun (2004) 0.81
Co-culture of human bone marrow stromal cells with endothelial cells alters gene expression profiles. Int J Artif Organs (2013) 0.80
Peripheral blood mononuclear phagocytes from patients with chronic periodontitis are primed for osteoclast formation. J Periodontol (2013) 0.80
The effects of xerogenic medications on oral mucosa among the Veterans Dental Study participants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 0.79
Comparison of the impact of scaler material composition on polished titanium implant abutment surfaces. J Dent Hyg (2013) 0.79
Enamel matrix derivative promotes superoxide production and chemotaxis but reduces matrix metalloproteinase-8 expression by polymorphonuclear leukocytes. J Periodontol (2011) 0.79
Blocking proinflammatory cytokine release modulates peripheral blood mononuclear cell response to Porphyromonas gingivalis. J Periodontol (2012) 0.79
Efficacy of a new papilla generation technique in implant dentistry: a preliminary study. Int J Oral Maxillofac Implants (2008) 0.78
Efficacy of a fluoridated hydrogen peroxide-based mouthrinse for the treatment of gingivitis: a randomized clinical trial. J Periodontol (2004) 0.78
CD38 expression in neutrophils from patients with localized aggressive periodontitis. J Periodontol (2005) 0.78
Effect of neutrophil apoptosis on monocytic cytokine response to Porphyromonas gingivalis lipopolysaccharide. J Periodontol (2005) 0.78
Change of antibiotic susceptibility following periodontal therapy. A pilot study in aggressive periodontal disease. J Clin Periodontol (2003) 0.77
The relationship between Porphyromonas gingivalis infection and local and systemic factors in children. J Periodontol (2004) 0.77
IgG antibody levels to Porphyromonas gingivalis and clinical measures in children. J Periodontol (2004) 0.77
Simultaneous measurements of cytoplasmic Ca2+ responses and intracellular pH in neutrophils of localized aggressive periodontitis (LAP) patients. J Leukoc Biol (2005) 0.77
Animal models for periodontal regeneration and peri-implant responses. Periodontol 2000 (2015) 0.76
IPLA2 mRNA expression by human neutrophils in type 2 diabetes and chronic periodontitis. J Int Acad Periodontol (2014) 0.76
Have we become so focused on inflammation and host response that we have neglected the role of bacteria in initiating periodontal disease? Compend Contin Educ Dent (2009) 0.76
Number of teeth, C-reactive protein, fibrinogen and cardiovascular mortality: a 15-year follow-up study in a Finnish cohort. J Clin Periodontol (2013) 0.76
Alternative splicing generates a diacylglycerol kinase α transcript that acts as a dominant-negative modulator of superoxide production in localized aggressive periodontitis. J Periodontol (2013) 0.75
Group A. Reactor Paper. Plaque control: home remedies practiced in developing countries. J Int Acad Periodontol (2015) 0.75